• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

勘误：整合素β5（ITGB5）通过促进DNA损伤修复和MEK/ERK信号通路，增强胰腺腺癌的固有辐射抗性。

Corrigendum: ITGB5 promotes innate radiation resistance in pancreatic adenocarcinoma by promoting DNA damage repair and the MEK/ERK signaling pathway.

作者信息

Wen Xin, Chen Si, Chen Xueting, Qiu Hui, Wang Wei, Zhang Nie, Liu Wanming, Wang Tingting, Ding Xin, Zhang Longzhen

机构信息

Department of Radiation Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.

Cancer Institute of Xuzhou Medical University, Xuzhou, China.

出版信息

Front Oncol. 2024 Feb 22;14:1381151. doi: 10.3389/fonc.2024.1381151. eCollection 2024.

DOI:10.3389/fonc.2024.1381151
PMID:38463236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10921090/
Abstract

[This corrects the article DOI: 10.3389/fonc.2022.887068.].

摘要

[本文更正了文章的数字对象标识符：10.3389/fonc.2022.887068。]

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c30f/10921090/4f3ddb2a1ccd/fonc-14-1381151-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c30f/10921090/043ef139ba97/fonc-14-1381151-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c30f/10921090/4f3ddb2a1ccd/fonc-14-1381151-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c30f/10921090/043ef139ba97/fonc-14-1381151-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c30f/10921090/4f3ddb2a1ccd/fonc-14-1381151-g007.jpg

相似文献

1
Corrigendum: ITGB5 promotes innate radiation resistance in pancreatic adenocarcinoma by promoting DNA damage repair and the MEK/ERK signaling pathway.勘误：整合素β5（ITGB5）通过促进DNA损伤修复和MEK/ERK信号通路，增强胰腺腺癌的固有辐射抗性。
Front Oncol. 2024 Feb 22;14:1381151. doi: 10.3389/fonc.2024.1381151. eCollection 2024.
2
ITGB5 promotes innate radiation resistance in pancreatic adenocarcinoma by promoting DNA damage repair and the MEK/ERK signaling pathway.整合素β5（ITGB5）通过促进DNA损伤修复和MEK/ERK信号通路，增强胰腺腺癌的固有辐射抗性。
Front Oncol. 2022 Sep 30;12:887068. doi: 10.3389/fonc.2022.887068. eCollection 2022.
3
Corrigendum: The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway.勘误：m6A甲基转移酶METTL16通过p21信号通路抑制胰腺腺癌细胞的增殖。
Front Oncol. 2023 May 19;13:1218781. doi: 10.3389/fonc.2023.1218781. eCollection 2023.
4
Corrigendum: EXOSC5 as a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer via Activating the ERK and AKT Pathways.勘误：EXOSC5作为一种新型预后标志物通过激活ERK和AKT通路促进结直肠癌增殖。
Front Oncol. 2021 Apr 9;11:670041. doi: 10.3389/fonc.2021.670041. eCollection 2021.
5
MEK inhibitor GSK1120212-mediated radiosensitization of pancreatic cancer cells involves inhibition of DNA double-strand break repair pathways.MEK抑制剂GSK1120212介导的胰腺癌细胞放射增敏作用涉及对DNA双链断裂修复途径的抑制。
Cell Cycle. 2015;14(23):3713-24. doi: 10.1080/15384101.2015.1104437.
6
Corrigendum: Systematic characterization of the clinical relevance of KPNA4 in pancreatic ductal adenocarcinoma.勘误：KPNA4在胰腺导管腺癌中的临床相关性的系统表征。
Front Oncol. 2023 Sep 11;13:1282120. doi: 10.3389/fonc.2023.1282120. eCollection 2023.
7
Identification of G-protein signaling modulator 2 as a diagnostic and prognostic biomarker of pancreatic adenocarcinoma: an exploration of its regulatory mechanisms.鉴定G蛋白信号调节因子2作为胰腺腺癌的诊断和预后生物标志物：对其调控机制的探索
J Gastrointest Oncol. 2021 Jun;12(3):1164-1179. doi: 10.21037/jgo-21-224.
8
Extracellular signal-regulated kinases modulate DNA damage response - a contributing factor to using MEK inhibitors in cancer therapy.细胞外信号调节激酶调节 DNA 损伤反应——这是在癌症治疗中使用 MEK 抑制剂的一个促成因素。
Curr Med Chem. 2011;18(35):5476-82. doi: 10.2174/092986711798194388.
9
Identification of novel candidate biomarkers for pancreatic adenocarcinoma based on TCGA cohort.基于TCGA队列鉴定胰腺腺癌的新型候选生物标志物
Aging (Albany NY). 2021 Feb 11;13(4):5698-5717. doi: 10.18632/aging.202494.
10
Corrigendum: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin.勘误：大黄素干扰AKT1介导的DNA损伤并降低乳腺癌细胞对多柔比星的耐药性。
Front Oncol. 2021 Jun 2;11:687841. doi: 10.3389/fonc.2021.687841. eCollection 2021.